Manipal Health IPO
Market Sentiment
IPO Details
IPO Reservation
Financial Analysis
| Metric | 2023 | 2024 | 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 4,927.57 | 6,265.17 | 9,409.12 | 5,436.31 |
| Expense | 4,225.20 | 5,340.51 | 8,664.15 | 4,867.55 |
| Profit (PAT) | 414.20 | 533.20 | 534.80 | 319.47 |
| Total Assets | 7,936.78 | 10,818.83 | 21,443.81 | 22,579.11 |
| Company | EPS | P/E | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 100.56 | 73.23 | 17.61 | 571.15 | 21,794.00 Cr |
| Fortis Healthcare Ltd | 10.26 | 80.12 | 8.68 | 118.11 | 7,782.75 Cr |
| Max Healthcare Institute Ltd | 11.07 | 87.63 | 11.47 | 96.50 | 8,667.00 Cr |
Promoters: Dr. Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd, Kangto Investments Pte. Ltd., Imperius Healthcare Investments Pte. Ltd., and Kabru Investments Pte. Ltd
Strengths & Risks
- Revenue grew 50% in the latest reported year.
No major red flags in the available data.
Auto-generated from live GMP, subscription, valuation and financial data. Informational only — not investment advice. Always read the RHP before applying.
Company Information
Manipal Health Enterprises Limited is a healthcare company in India that runs many hospitals, clinics, and diagnostic centres. It is part of the Manipal Group, which was started by T. M. A. Pai. Moreover, the company provides different types of medical services such as organ transplants, oncology, cardiology, neurology, orthopaedics, and preventive healthcare. The company has a major of give good quality care to patients and make healthcare more available. As of September 30, 2025, the company runs 38 hospitals (or 48 hospitals on a pro forma basis) with 10,761 beds (or 12,367 licensed beds on a pro forma basis). It also operates 17 clinics.
| Purpose | Amount (Cr) |
|---|---|
| Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of the Material Subsidiaries, Manipal Hospitals Private Limited | 5,378.00 |
| Acquisition of minority stake in the stepdown Subsidiary, Sahyadri Hospitals Private Limited | 574.00 |
| General corporate purposes | - |
Resources & Documents
Manipal Health Enterprises Ltd., The Annexe,, 98/2, Rustom Bagh,, HAL Airport Road,, Bengaluru, Karnataka, 560017
Manipal Health is preparing a mainboard offering. The Mainboard issue is scheduled to open for subscription on July 27, 2026 — 10 days from now.
Manipal Health Enterprises Limited is a healthcare company in India that runs many hospitals, clinics, and diagnostic centres. It is part of the Manipal Group, which was started by T.
The issue is promoted by Dr. Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd, Kangto Investments Pte. Ltd., Imperius Healthcare Investments Pte. Ltd., and Kabru Investments Pte. Ltd with Kotak Mahindra Capital Company Limited, Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited,… acting as lead manager. Net proceeds will primarily be used towards Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one… (Rs 5,378 crore) and Acquisition of minority stake in the stepdown Subsidiary, Sahyadri Hospitals Private Limited (Rs 574 crore).
On fundamentals, the company is posting revenue growth of 50.2%, a profit margin of 5.7% in its most recent reported period. Listed peers in this segment include Apollo Hospitals Enterprise Ltd (P/E 73.23x) and Fortis Healthcare Ltd (P/E 80.12x) — useful reference points when evaluating the issue's pricing relative to where the broader sector are trading.
All figures below — GMP history, subscription tiers, financials and peers — are aggregated from public disclosures. Always apply through your own broker after reading the RHP.
Manipal Health IPO GMP — What It Means
No active grey market premium has been recorded for Manipal Health IPO yet. GMP is an unofficial, dealer-quoted indicator of expected listing-day demand — not a guaranteed listing price — and it can change quickly once bidding opens.
See the full Manipal Health GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
No comments yet. Be the first to share your opinion!